ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,475Medicare Part D Prescriptions Filled, Including Refills

Rank: 97 out of 3734

$893K Total Retail Price of All Prescriptions

Rank: 155 out of 3734

599 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 14,453 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 785 654 1 3
LEVOTHYROXINE SODIUM 724 647 2 2
SIMVASTATIN 710 614 3 1
HYDROCODONE-ACETAMINOPHEN 449 245 S3 4 12
FUROSEMIDE 439 356 5 7
ATENOLOL 379 307 6 13
OMEPRAZOLE 361 282 7 4
WARFARIN SODIUM 355 309 8 10
CARVEDILOL 347 302 9 30
METFORMIN HCL 314 268 10 8
AMLODIPINE BESYLATE 306 262 11 5
GABAPENTIN 281 211 12 17
PRAVASTATIN SODIUM 277 238 13 15
ATORVASTATIN CALCIUM 267 232 14 11
METOPROLOL TARTRATE 262 226 15 6
PANTOPRAZOLE SODIUM 226 197 16 22
RAMIPRIL 184 143 17 91
CLOPIDOGREL 183 157 18 23
AZITHROMYCIN 181 134 19 38
DONEPEZIL HCL 173 172 20 25
POTASSIUM CHLORIDE 167 158 21 19
GLIMEPIRIDE 164 159 22 37
SERTRALINE HCL 158 128 23 18
RANITIDINE HCL 153 122 24 32
KLOR-CON M20 151 123 25 48
ADVAIR DISKUS 145 96 26 35
ZETIA 143 139 27 55
CIPROFLOXACIN HCL 141 123 28 77
LANTUS 140 126 29 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 139 109 30 27
PLAVIX 135 117 31 39
TRAMADOL HCL 134 105 32 20
PREDNISONE 132 105 33 42
PAROXETINE HCL 131 100 34 59
TAMSULOSIN HCL 126 115 35 29
LOSARTAN POTASSIUM 124 95 36 21
METOPROLOL SUCCINATE 123 117 37 14
METFORMIN HCL ER 123 120 37 66
HYDROCHLOROTHIAZIDE 120 118 39 9
ALLOPURINOL 117 108 40 33
DILTIAZEM 24HR ER 114 112 41 86
FENTANYL 111 100 S2 42 65
DIGOXIN 107 94 43 43
CITALOPRAM HBR 105 95 44 16
NEXIUM 100 60 45 36
ISOSORBIDE MONONITRATE ER 100 91 45 34
LOSARTAN-HYDROCHLOROTHIAZIDE 94 77 47 71
ZOLPIDEM TARTRATE 90 79 48 24
MIRTAZAPINE 89 77 49 45
OXYBUTYNIN CHLORIDE ER 88 75 50 141
SPIRONOLACTONE 86 52 51 80
DIOVAN HCT 85 85 52 72
CYMBALTA 84 37 53 67
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 76 54 117
ALENDRONATE SODIUM 80 76 55 26
BUMETANIDE 77 64 56 78
TRAZODONE HCL 76 61 57 49
SINGULAIR 76 29 57 95
TRICOR 72 46 59 93
DIOVAN 72 66 59 31
AGGRENOX 68 59 61 182
DILTIAZEM 24HR CD 66 66 62 97
VENLAFAXINE HCL ER 64 45 63 84
MELOXICAM 64 34 63 52
CARBIDOPA-LEVODOPA 63 63 65 92
DOXAZOSIN MESYLATE 62 50 66 100
ROPINIROLE HCL 62 46 66 118
KLOR-CON 10 59 38 68 140
TRIAMTERENE-HCTZ 56 41 69 73
TORSEMIDE 55 46 70 160
NAMENDA 53 53 71 44
FINASTERIDE 53 53 71 88
INSULIN SYRINGE 53 51 71 109
MECLIZINE HCL 53 53 71 139
CEPHALEXIN 53 47 71 120
LIPITOR 52 52 76 90
TERAZOSIN HCL 52 40 76 136
PROPRANOLOL HCL 51 42 78 126
QUINAPRIL HCL 51 51 78 74
GLIPIZIDE XL 50 25 80 85
ACTONEL 50 49 80 188
CYCLOBENZAPRINE HCL 50 24 R 80 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.